Clinical Trial Update: COPARIME: Pilot Study of a Target Detection of Malignant Melanoma [NA]

View source ↗

Summary

Pilot study COPARIME evaluating target detection of malignant melanoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Snippet

Sponsor: Nantes University Hospital | Conditions: Patients at Risk for Melanoma | NA | Status: COMPLETED